NGUYEN, THI PHUONG NHUNG

NGUYEN, THI PHUONG NHUNG  

100008 - Dipartimento di medicina sperimentale  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.029 secondi).
Titolo Data di pubblicazione Autore(i) File
A repurposing approach to delay disease progression in SOD1G93A mice by counteracting oligodendrocyte dysfunction 1-gen-2023 Raffaele, S.; Bonifacino, T.; Nguyen, N.; Boccazzi, M.; Frumento, G.; Milanese, M.; Bonanno, G.; Abbracchio, M. P.; Fumagalli., M.
A repurposing approach to improve disease outcome in SOD1G93A mice by counteracting oligodendrocyte dysfunction and neuroinflammation 1-gen-2023 Raffaele, Stefano; Nguyen, Nhung; Boccazzi, Marta; Frumento, Giulia; Milanese, Marco; Mannella, Francesca C.; Lambertsen, Kate L.; Madsen, Kirsten; Schroeder, Henrik D.; Hejbøl, Eva K.; Bonanno, Giambattista; Abbracchio, Maria P.; Bonifacino, Tiziana; Fumagalli, Marta
EFFECTS OF PHARMACOLOGICAL GPR17 MODULATION IN THE SOD1G93A MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS 11-mag-2023 Nguyen, THI PHUONG NHUNG
Effects of the GPR17 antagonist montelukast on oligodendrocyte dysfunction and disease outcome in the SOD1G93A mouse model of ALS 1-gen-2021 Bonifacino, T; Raffaele, S; Nguyen, N; Milanese, M; Bonanno, G; Abbracchio, Mp; Fumagalli, M
In-vivo treatment with the GPR17 antagonist montelukast ameliorated the lifespan and delayed the disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 1-gen-2022 Nguyen, Nhung; Milanese, M.; Raffaele, S.; Zerbo, R. A.; Fumagalli, M.; Abbracchio, M. P.; Bonanno, G.; Bonifacino, T.
In-vivo treatment with the GPR17 antagonist montelukast improves lifespan and delays disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 1-gen-2022 Bonifacino, T.; Nguyen, T. P. N.; Raffaele, S.; Frumento, G.; Milanese, M.; Abbracchio, M. P.; Bonanno, G.; Fumagalli, M.
Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders 1-gen-2022 Kumar, Mandeep; Nguyen, THI PHUONG NHUNG; Milanese, Marco; Bonanno, Giambattista
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases 1-gen-2022 Nguyen, THI PHUONG NHUNG; Kumar, Mandeep; Fedele, Ernesto; Bonanno, Giambattista; Bonifacino, Tiziana
Montelukast improves disease outcome in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity 1-gen-2024 Raffaele, S.; Nguyen, N.; Milanese, M.; Mannella, F. C.; Boccazzi, M.; Frumento, G.; Bonanno, G.; Abbracchio, M. P.; Bonifacino, T.; Fumagalli, M.
Montelukast improves disease outcomes in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity 1-gen-2024 Bonifacino, T.; Raffaele, S.; Nguyen, N.; Boccazzi, M.; Frumento, G.; Milanese, M.; Bonanno, G.; Abbracchio, M. P.; Fumagalli, M.
Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity 1-gen-2023 Bonifacino, Tiziana; Raffaele, Stefano; Nguyen, THI PHUONG NHUNG; Marta, Boccazzi; Frumento, Giulia; Milanese, Marco; Bonanno, Giambattista; Abbracchio Maria Pia, ; Marta, Fumagalli
Pharmacological blockade of the P2Y-like GPR17 receptor with montelukast delays disease progression by counteracting oligodendrocyte dysfunction in the SOD1G93A mouse model of amyotrophic lateral sclerosis 1-gen-2022 Raffaele, Stefano; Nguyen, THI PHUONG NHUNG; Boccazzi, Marta; Frumento, Giulia; Milanese, Marco; Bonanno, Giambattista; Abbracchio Maria, Pia; Bonifacino, Tiziana; Fumagalli, Marta